ORCID
- Hanemann, Oliver: 0000-0002-1951-1025
DOI
10.1158/1535-7163.MCT-16-0821
Publication Date
2017-04-20
Publication Title
Molecular Cancer Therapeutics
First Page
molcanther.0821.2016
Last Page
molcanther.0821.2016
ISSN
1535-7163
Embargo Period
2018-05-03
Organisational Unit
Peninsula Medical School
Recommended Citation
Cooper, J., Xu, Q., Zhou, L., Pavlovic, M., Ojeda, V., Moulick, K., de, S., Poirier, J., Zauderer, M., Rudin, C., Karajannis, M., Hanemann, C., & Giancotti, F. (2017) 'Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis', Molecular Cancer Therapeutics, , pp. molcanther.0821.2016-molcanther.0821.2016. Available at: https://doi.org/10.1158/1535-7163.MCT-16-0821
